One is a maternal RSV vaccine—Pfizer's Abrysvo, approved in 2023—that can be given to pregnant people during the third trimester (weeks 32 to 36), and is also approved for adults over age 60. The most ...

IT’S that time of year where parents brace themselves for an onslaught of winter bugs. With health bosses warning of a spike ...

A study has highlighted ways to reduce RSV infections - including a vaccine programme which could reduce antibiotic ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

Cambridge: Moderna, Inc. has announced Health Canada has approved mRESVIA (Respiratory Syncytial Virus mRNA vaccine) for ...

Public health officials reiterated the importance of vaccines after seeing a rise in circulating levels of respiratory syncytial virus (RSV).

Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...

Mississauga: GSK's AREXVY (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) has been approved in Canada ...

“It is a good idea to get your flu jab every year and to make sure you have the pneumonia vaccine, Covid-19 vaccination and the RSV vaccination if you are eligible,” recommends Whittamore. “Make sure ...

Health Canada approves Moderna’s RSV vaccine, mRESVIA for adults aged 60 years and older: Cambridge, Massachusetts Monday, November 11, 2024, 12:00 Hrs [IST] Moderna, Inc., a le ...

A new free vaccination program from the Australian government is intended to protect pregnant women and babies from the ...